Researchers used data from the CT Perfusion (CTP) to Predict Response to Recanalization in Ischemic Stroke Project to examine the relationship between time to endovascular treatment and the probability of good outcomes in stroke.
Subanalysis results from the SWIFT PRIME trial indicate that stent-retriever based reperfusion within 150 minutes of stroke symptom onset.
At 3 months, women and minorities had worse functional status following stroke.
Stroke risk was associated with fewer than 7 to 8 hours of sleep per night compared with those who slept longer than 8 hours or shorter than 7 hours.Vigorous leisure activity 3 to 6 times per week also significantly decreased stroke risk.
REVERSE-AD trial’s initial results have demonstrated idarucizumab may function as a reversal agent for dabigatran-treated patients with intracranial hemorrhage.
A positive, complex association between air pollution, temperature, and stroke prevalence in the US and China has been established.
In patients with insulin resistance, pioglitazone reduced recurrent stroke or myocardial infarction by relative risk of 24%, which translates to 28 prevented strokes or myocardial infarctions per 1000 patients.
ACT I and CREST clinical trial results demonstrate noninferiority between carotid artery stenting and carotid endarterectomy in patients with severe carotid artery stenosis.
CLEAR III trial findings indicate multiple catheters in external ventricular drain treatment, as well as higher doses of alteplase, result in better efficiency and recovery.
Patients with cryptogenic stroke had a significantly higher proportion of intraplaque high-intensity signal in internal cartoid artery plaques ipsilateral to the side of infarction that was not seen in patients with strokes stemming from cardioembolism or small-vessel occlusion.
